Literature DB >> 18024614

Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease.

Marilyn J Telen1.   

Abstract

A number of lines of evidence now support the hypothesis that vaso-occlusion and several of the sequelae of sickle cell disease (SCD) arise, at least in part, from adhesive interactions of sickle red blood cells, leukocytes, and the endothelium. Both experimental and genetic evidence provide support for the importance of these interactions. It is likely that future therapies for SCD might target one or more of these interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18024614     DOI: 10.1182/asheducation-2007.1.84

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  18 in total

1.  Epinephrine modulates BCAM/Lu and ICAM-4 expression on the sickle cell trait red blood cell membrane.

Authors:  Jamie L Maciaszek; Biree Andemariam; Greg Huber; George Lykotrafitis
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

Review 2.  Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.

Authors:  Ram Kalpatthi; Enrico M Novelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Regulation of Active ICAM-4 on Normal and Sickle Cell Disease RBCs via AKAPs Is Revealed by AFM.

Authors:  Jing Zhang; Krithika Abiraman; Sasia-Marie Jones; George Lykotrafitis; Biree Andemariam
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

4.  Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?

Authors:  Marilyn J Telen
Journal:  Blood Adv       Date:  2020-07-28

5.  Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease.

Authors:  Magda O Seixas; Larissa C Rocha; Mauricio B Carvalho; Joelma F Menezes; Isa M Lyra; Valma M L Nascimento; Ricardo D Couto; Ájax M Atta; Mitermayer G Reis; Marilda S Goncalves
Journal:  Lipids Health Dis       Date:  2010-08-27       Impact factor: 3.876

6.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

7.  Factors associated with survival in a contemporary adult sickle cell disease cohort.

Authors:  Hany Elmariah; Melanie E Garrett; Laura M De Castro; Jude C Jonassaint; Kenneth I Ataga; James R Eckman; Allison E Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2014-02-21       Impact factor: 10.047

8.  Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease.

Authors:  Rabindra Paul; Caterina P Minniti; Mehdi Nouraie; Lori Luchtman-Jones; Andrew Campbell; Sohail Rana; Onyinye Onyekwere; Deepika S Darbari; Olaid Ajayi; Manuel Arteta; Gregory Ensing; Craig Sable; Niti Dham; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  Eur J Haematol       Date:  2013-05-03       Impact factor: 2.997

9.  Synthesis and pharmacological evaluation of pomalidomide derivatives useful for sickle cell disease treatment.

Authors:  Thais Regina Ferreira de Melo; Brian M Dulmovits; Guilherme Felipe Dos Santos Fernandes; Cristiane M de Souza; Carolina Lanaro; Minghzu He; Yousef Al Abed; Man Chin Chung; Lionel Blanc; Fernando Ferreira Costa; Jean Leandro Dos Santos
Journal:  Bioorg Chem       Date:  2021-06-10       Impact factor: 5.307

10.  Red Blood Cells: Tethering, Vesiculation, and Disease in Micro-Vascular Flow.

Authors:  Robert J Asaro; Pedro Cabrales
Journal:  Diagnostics (Basel)       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.